Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 10/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.65 |
| ▸ | EP300 | Q09472 | 1/20 | 0.63 |
| ▸ | CA12 | O43570 | 1/20 | 0.60 |
| ▸ | CA1 | P00915 | 1/20 | 0.60 |
| ▸ | CA2 | P00918 | 1/20 | 0.60 |
| ▸ | CA7 | P43166 | 1/20 | 0.60 |
| ▸ | CA9 | Q16790 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.57 |
| ▸ | MEN1 | O00255 | 5/20 | 0.57 |
| ▸ | RECQL | P46063 | 1/20 | 0.57 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.57 |
| ▸ | XDH | P47989 | 1/20 | 0.57 |
| ▸ | CISD1 | Q9NZ45 | 2/20 | 0.53 |
| ▸ | MAOA | P21397 | 1/20 | 0.53 |
| ▸ | MAOB | P27338 | 1/20 | 0.53 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17717968 | 0.90 | CA12 (0.71) | MAPTKDM4EEP300CA12CA1 | |
| SCHEMBL31424240 | 0.89 | CA12 (0.58) | MAPTKDM4EEP300CA12CA1 | |
| SCHEMBL7432799 | 0.88 | EP300 (0.62) | MAPTKDM4EEP300CA12CA1 | |
| SCHEMBL7432791 | 0.88 | EP300 (0.62) | MAPTKDM4EEP300CA12CA1 | |
| SCHEMBL17717936 | 0.86 | MAPT (0.63) | MAPTKDM4EEP300CA12CA1 | |
| SCHEMBL16979817 | 0.86 | EP300 (0.66) | MAPTKDM4EEP300CA12CA1 | |
| SCHEMBL2719600 | 0.85 | CA12 (0.54) | MAPTKDM4EEP300CA12CA1 | |
| SCHEMBL15044605 | 0.82 | MAPT (0.65) | MAPTKDM4EEP300CA12CA1 | |
| SCHEMBL13751815 | 0.81 | CA12 (0.61) | MAPTKDM4EEP300CA12CA1 | |
| SCHEMBL24077379 | 0.78 | CA12 (0.58) | MAPTKDM4EEP300CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119735614-A | 1-Phosphanorbornene-dimethyl xanthene chiral ligand and synthetic method and application thereof | 河南工业大学 | 2025-04-01 | — | — | CN | disclosed |
| CN-119431387-A | Spirobarbituric acid-epoxyhexane compound and synthetic method and application thereof | 河南工业大学 | 2025-02-14 | — | — | CN | disclosed |
| EP-4383990-A1 | MATERIALS FOR OPTOELECTRONIC APPLICATIONS | The Regents Of The University Of Michigan (US) | 2024-06-12 | — | — | EP | disclosed |
| CN-117836333-A | Free radically polymerizable composition, method of polymerization, and polymerized composition | 3M创新有限公司 | 2024-04-05 | — | — | CN | disclosed |
| WO-2023031719-A1 | FREE-RADICALLY POLYMERIZABLE COMPOSITION, METHOD OF POLYMERIZING THE SAME, AND POLYMERIZED COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2023-03-09 | — | — | WO | disclosed |
| CN-108358831-B | Polysubstituted carbazole derivative and preparation method thereof | 山东师范大学 | 2020-09-29 | — | — | CN | disclosed |
| US-8900785-B2 | Charge control agent and toner using the same | HODOGAYA CHEMICAL CO., LTD. (JP) | 2014-12-02 | — | — | US | disclosed |
| US-8900785-B2 | Charge control agent and toner using the same | HODOGAYA CHEMICAL CO., LTD. (JP) | 2014-12-02 | — | — | US | disclosed |
| US-8900785-B2 | Charge control agent and toner using the same | HODOGAYA CHEMICAL CO., LTD. (JP) | 2014-12-02 | — | — | US | disclosed |
| CN-103238117-A | Charge control agent and toner using same | HODOGAYA CHEMICAL CO LTD | 2013-08-07 | — | — | CN | disclosed |
| EP-2618219-A1 | CHARGE CONTROL AGENT AND TONER USING SAME | Hodogaya Chemical Co., Ltd. (JP) | 2013-07-24 | — | — | EP | disclosed |
| EP-2618219-A1 | CHARGE CONTROL AGENT AND TONER USING SAME | Hodogaya Chemical Co., Ltd. (JP) | 2013-07-24 | — | — | EP | disclosed |
| US-20130157190-A1 | CHARGE CONTROL AGENT AND TONER USING THE SAME | HODOGAYA CHEMICAL CO., LTD. (JP) | 2013-06-20 | — | — | US | disclosed |
| US-20130157190-A1 | CHARGE CONTROL AGENT AND TONER USING THE SAME | HODOGAYA CHEMICAL CO., LTD. (JP) | 2013-06-20 | — | — | US | disclosed |
| US-20130157190-A1 | CHARGE CONTROL AGENT AND TONER USING THE SAME | HODOGAYA CHEMICAL CO., LTD. (JP) | 2013-06-20 | — | — | US | disclosed |
| EP-1305026-B1 | BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS | NOVUSPHARMA SPA (IT) | 2009-05-13 | — | — | EP | disclosed |
| US-20080113993-A1 | BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS | VIA ARIOSTO, 23 (IT) | 2008-05-15 | — | — | US | disclosed |
| US-20080113993-A1 | BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS | VIA ARIOSTO, 23 (IT) | 2008-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080113993-A1 | BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS | HIF1A, HIF1AN, PDGFA | MAPT 3423/4885KDM4E 688/4885EP300 4/4885 |
| US-20130157190-A1 | CHARGE CONTROL AGENT AND TONER USING THE SAME | GABRR1, GABRR2, GABRR3 | MAPT 1617/4885KDM4E 753/4885EP300 1531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.